Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Asymptomatic left ventricular dysfunction in the community.

T A McDonagh1

  • 1Department of Medical Cardiology, University of Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow, G31 6ER, Scotland. t. mcdonagh@bio.gla.ac.uk

Current Cardiology Reports
|September 12, 2000
PubMed
Summary

Asymptomatic left ventricular dysfunction (ALVD) is common and linked to poor outcomes. Early detection using brain natriuretic peptide (BNP) tests can identify individuals at risk for chronic heart failure (CHF).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Newly diagnosed heart failure: change in quality of life, mood, and illness beliefs in the first 6 months after diagnosis.

British journal of health psychology·2011
Same author

Treatment of left ventricular non-compaction with cardiac resynchronization therapy.

QJM : monthly journal of the Association of Physicians·2011
Same author

Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK.

Heart (British Cardiac Society)·2009
Same author

N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation.

Heart (British Cardiac Society)·2005
Same author

Lessons from the management of chronic heart failure.

Heart (British Cardiac Society)·2005
Same author

The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones?

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2005

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Biomarker Research

Background:

  • Chronic heart failure (CHF) often stems from left ventricular dysfunction (LVD), frequently systolic.
  • A significant phase of asymptomatic LVD (ALVD) precedes symptomatic CHF, impacting quality of life and survival.
  • Ischemic heart disease is a primary cause of ALVD, which affects individuals as frequently as CHF.

Purpose of the Study:

  • To review the epidemiology of asymptomatic left ventricular dysfunction (ALVD).
  • To explore the potential of natriuretic peptide hormones, particularly brain natriuretic peptide (BNP), in detecting ALVD.
  • To assess BNP's utility as a cost-effective screening tool for LVD.

Main Methods:

  • Epidemiological review of ALVD prevalence and characteristics.

Related Experiment Videos

  • Analysis of natriuretic peptide hormone levels (atrial natriuretic peptide and brain natriuretic peptide) in ALVD subjects.
  • Evaluation of brain natriuretic peptide (BNP) accuracy and predictive values for detecting LVD.

    • Main Results:

    • ALVD is as prevalent as CHF, primarily caused by ischemic heart disease, and associated with reduced quality of life and increased mortality.
    • Elevated levels of natriuretic peptide hormones, including BNP, are observed in individuals with ALVD.
    • BNP demonstrates high accuracy and a strong negative predictive value for detecting LVD in the general population.

    Conclusions:

    • ALVD is a significant condition with substantial morbidity and mortality, warranting screening.
    • Brain natriuretic peptide (BNP) is a valuable and accurate biomarker for detecting LVD, even in asymptomatic individuals.
    • BNP testing offers a cost-effective strategy for identifying individuals with LVD, optimizing specialist referrals and echocardiography use.